Tyler Jacks
Tyler Jacks | |
|---|---|
Tyler Jacks | |
| Education | Harvard University University of California, San Francisco |
| Known for | Genetically engineered mouse models (GEMMs) of human cancer; tumor-immune interactions; promoting inter-disciplinary and inter-institutional collaboration in cancer research |
| Scientific career | |
| Fields | Cancer Biology; Cancer Genetics; Tumor Immunology |
| Workplaces | David H. Koch Institute for Integrative Cancer Research Massachusetts Institute of Technology Break Through Cancer |
| Harold E. Varmus | |
Other academic advisors | Robert Weinberg |
Tyler Jacks is an American cancer biologist and the David H. Koch Professor of Biology at the Massachusetts Institute of Technology (MIT). He is the founding director of MIT's David H. Koch Institute for Integrative Cancer Research and its successor, the Koch Institute, from 2001 to 2021. Jacks was a Howard Hughes Medical Institute investigator from 1994 to 2021, when he became president of Break Through Cancer. His research is best known for the development and analysis of genetically engineered mouse models (GEMMS), a foundational contribution to modern cancer biology that has helped shape how scientists study tumor initiation, progression, and the treatment response across every major cancer type.